LEADER 02759nam 22006015 450 001 9910686782603321 005 20251009080531.0 010 $a9783031235702 010 $a3031235703 024 7 $a10.1007/978-3-031-23570-2 035 $a(CKB)5590000001034508 035 $a(DE-He213)978-3-031-23570-2 035 $a(PPN)269095896 035 $a(MiAaPQ)EBC7233646 035 $a(Au-PeEL)EBL7233646 035 $a(OCoLC)1375010687 035 $a(EXLCZ)995590000001034508 100 $a20230331d2023 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBest Practice Guideline for Statistical Analyses of Fatigue Results /$fby Guy Parmentier, Michel Huther, Isabel Huther, Fabien Lefebvre 205 $a1st ed. 2023. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2023. 215 $a1 online resource (IX, 117 p. 24 illus., 17 illus. in color.) 225 1 $aIIW Collection,$x2365-4368 311 08$a9783031235696 311 08$a303123569X 330 $aThis book provides a comprehensive guidance for the use of sound statistical methods and for the evaluation of fatigue data of welded components and structures obtained under constant amplitude loading and used to produce S-N curves. Recommendations for analyzing fatigue data are available, although they do not deal with all the statistical treatments that may be required to utilize fatigue test results, and none of them offers specific guidelines for analyzing fatigue data obtained from tests on welded specimens. For an easy use, working sheets are provided to assist in the proper statistical assessment of experimental fatigue data concerning practical problems giving the procedure and a numerical application as illustration. . 410 0$aIIW Collection,$x2365-4368 606 $aMaterials$xFatigue 606 $aStatistics 606 $aMaterials Fatigue 606 $aApplied Statistics 615 0$aMaterials$xFatigue. 615 0$aStatistics. 615 14$aMaterials Fatigue. 615 24$aApplied Statistics. 676 $a620.112 676 $a671.52042 700 $aParmentier$b Guy$4aut$4http://id.loc.gov/vocabulary/relators/aut$0476203 702 $aHuther$b Michel$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aHuther$b Isabel$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aLefebvre$b Fabien$4aut$4http://id.loc.gov/vocabulary/relators/aut 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910686782603321 996 $aBest Practice Guideline for Statistical Analyses of Fatigue Results$93255638 997 $aUNINA LEADER 05735nam 22006855 450 001 9911015683203321 005 20250711141931.0 010 $a9783031924019$b(electronic bk.) 010 $z9783031924002 024 7 $a10.1007/978-3-031-92401-9 035 $a(MiAaPQ)EBC32207542 035 $a(Au-PeEL)EBL32207542 035 $a(CKB)39633456900041 035 $a(DE-He213)978-3-031-92401-9 035 $a(OCoLC)1544985980 035 $a(EXLCZ)9939633456900041 100 $a20250711d2025 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aTMS and Neuroethics /$fedited by Veljko Dubljevi?, Jonathan R. Young 205 $a1st ed. 2025. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2025. 215 $a1 online resource (391 pages) 225 1 $aAdvances in Neuroethics,$x2522-5685 311 08$aPrint version: Dubljevi?, Veljko TMS and Neuroethics Cham : Springer,c2025 9783031924002 327 $a1. An Introduction to TMS and Neuroethics -- Part I. Historical and Philosophical Reflections regarding TMS -- 2. A History of Transcranial Magnetic Stimulation -- 3. Racial Disparities in rTMS Research Participation and Clinical Access in the U.S -- 4. Family and Caregiver Perspectives on TMS Treatment of Refractory Conditions: A Pilot Investigation -- 5. Transcranial Magnetic Stimulation and Cognitive Enhancement: Present State and Possibilities for the Near Future -- 6. Unravelling Ethical Complexities: Transcranial Magnetic Stimulation (TMS) in Non-clinical Settings and the Dilemmas of Neuroenhancement -- 7. TMS for social neuroscience: New applications and ethical issues -- 8. "Bridging Network Neuroscience and Neuroethics: Can TMS and tACS Solve the Creativity Crisis?" -- Part II. New directions and ethical issues in clinical TMS research -- 9. Subgrouping ?Treatment Responders?: Ethical Implications for Those Seeking Participation in TMS Treatment and/or Research -- 10. TMS for mood disorders ? an ethical perspective -- 11. ?The fewer pills the better?: Attitudes towards Transcranial Magnetic Stimulation for Depressed Adolescents -- 12. Transcranial Magnetic Stimulation in Older Adults -- 13. The Ethics of TMS in the Treatment of Suicidal Ideation -- 14. Transcranial Magnetic Stimulation for Substance Use Disorders: Ethical Considerations -- 15. Regulatory Perspectives on Transcranial Magnetic Stimulation. 330 $aAs transcranial magnetic stimulation (TMS) continues to expand from a tool of neuroscience research into a growing array of clinical applications, it presents a number of open questions that both invite and complicate ethical evaluation. Empirically supported concerns remain regarding interactions between TMS and psychiatric medications or other interventions, the potential for adverse effects in stimulated brain regions, and whether modulation of brain activity?particularly via changes in oscillatory states?might affect aspects of personhood. This volume explores the ethical landscape surrounding TMS in both research and clinical settings. Prior neuroethics literature has largely focused on theoretical implications of neurostimulation technologies, including conceptual clarification (e.g., invasiveness) and normative questions regarding the alignment of these technologies with societal values. However, while some empirical work has captured perspectives from TMS patients, many key voices?such as those of family members, clinicians, and underrepresented communities?have remained absent from scholarly discussions. Spanning historical reflection, theoretical debate, empirical analysis, and clinical insight, this collection features contributions from scholars and practitioners working at the intersection of neuroethics, neuroscience, psychiatry, and biomedical engineering. Part I of the volume offers historical and theoretical reflections, including the origins and growth of TMS research, racial disparities in access and participation, caregiver perspectives, and emerging issues related to cognitive enhancement, non-clinical use, and applications in social neuroscience and creativity. Part II turns to new directions and ethical issues in clinical TMS research, addressing treatment subgrouping, adolescent and geriatric use, mood and substance use disorders, suicidality, and the evolving regulatory landscape. Together, these chapters provide an interdisciplinary examination of the ethical, clinical, and societal dimensions of TMS. Whether as an introduction to the neuroethics of brain stimulation or as a resource for neuroscientists, clinicians, engineers, and ethicists, this volume aims to foster greater understanding and dialogue around the responsible development and application of TMS. 410 0$aAdvances in Neuroethics,$x2522-5685 606 $aNeurology 606 $aMedical ethics 606 $aPsychiatry 606 $aNeurosciences 606 $aPhilosophy 606 $aNeurology 606 $aMedical Ethics 606 $aPsychiatry 606 $aNeuroscience 606 $aPhilosophy 615 0$aNeurology. 615 0$aMedical ethics. 615 0$aPsychiatry. 615 0$aNeurosciences. 615 0$aPhilosophy. 615 14$aNeurology. 615 24$aMedical Ethics. 615 24$aPsychiatry. 615 24$aNeuroscience. 615 24$aPhilosophy. 676 $a616.8 700 $aDubljevic?$b Veljko$00 701 $aYoung$b Jonathan R$01833740 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9911015683203321 996 $aTMS and Neuroethics$94408704 997 $aUNINA